Edap Tms (EDAP) Equity Average (2025 - 2026)
Edap Tms (EDAP) reported Equity Average of $14.8 million for Q1 2026, down 63.55% on a YoY basis from $40.5 million in Q1 2025, and down 63.55% quarter-over-quarter from $40.5 million in Q1 2025.
Edap Tms (EDAP) Equity Average (2025 - 2026) Analysis & Trends
Edap Tms has reported Equity Average for 2 years, with the latest figure at $14.8 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 63.55% year-over-year to $14.8 million; the trailing twelve-month figure through Mar 2026 stood at $14.8 million (down 63.55% YoY), and the FY2025 full-year result was $30.9 million, down 41.26% from the prior year.
- Equity Average for Q1 2026 stood at $14.8 million, down from $40.5 million in the prior quarter.
- The five-year high for Equity Average was $40.5 million in Q1 2025, with the low at $14.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 198.73 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -1.34 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.84 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -2.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.58 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -462.87 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 14.76 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -98.90 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 19.13 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 5.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.76 Mn |
| Mar 31, 2025 | 40.48 Mn |